查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1916495

全球动物药品市场：市场规模、份额、成长率、产业分析、按类型、应用和地区划分的考量因素以及未来预测（2026-2034）

Veterinary Drugs Market Size, Share, Growth and Global Industry Analysis By Type & Application, Regional Insights and Forecast to 2026-2034
出版日期: | 出版商: Fortune Business Insights Pvt. Ltd. | 英文 180 Pages | 商品交期: 请询问到货日

价格

动物药品市场成长驱动因素

全球动物药品市场在保护动物健康、确保食品安全和预防人畜共通传染病传播方面发挥着至关重要的作用。根据报告的预测，到2025年，全球动物药品市场规模预计将达到305.4亿美元。在动物疾病发病率上升、宠物饲养量增加以及对动物性蛋白质需求成长的推动下，预计到2026年，该市场规模将达到322亿美元。在长期预测期内，伴侣动物和牲畜市场预计都将保持稳定持续成长，到2034年将达到530.5亿美元。

动物药品用于预防、诊断、缓解和治疗动物疾病，并维持动物的最佳生理功能。抗感染药、驱虫药、抗发炎药物和其他治疗药物可解决多种动物健康问题，包括牛呼吸道疾病、口蹄疫、禽流感、乳房炎、寄生虫病和皮肤病。全球人畜共通传染病和传染病发病率的不断上升，进一步凸显了有效动物治疗药物的重要性。

市场动态

兽药市场的主要驱动因素是牲畜和伴侣动物兽医疾病的日益增加。疾病发生率的上升推动了对预防和治疗药物的需求，尤其是在牲畜数量多、密集养殖的地区。各国政府和动物卫生组织积极支持疫苗接种计划、疾病监测和宣传活动，进一步促进了药物的使用。

另一个重要的成长因素是宠物主人数量的增加以及伴侣动物的人性化。宠物主人将动物视为家庭成员，并愿意投资先进的兽医护理、常规药物和预防性治疗。这一趋势正在推动对高端动物药品的需求，包括生物製剂、单株抗体和疼痛管理疗法。

然而，非法和假冒动物药品阻碍了市场发展。未经许可的产品加剧了抗菌素抗药性，并削弱了人们对正规药品的信任，对动物健康、食品安全和公共卫生构成威胁。监管机构正在持续加强执法力度，以遏制非法药品的流通。

市场机会与挑战

全球宠物数量的成长和可支配收入的增加为动物药品生产商提供了巨大的机会。日常兽医护理、疫苗接种和慢性病管理的支出增加，催生了对创新和专业化药品的需求。新兴国家兽医服务的扩张也进一步支撑了市场潜力。

同时，市场也面临与抗菌素抗药性（AMR）相关的挑战。动物抗生素的过度使用和滥用导致抗药性加速发展，促使监管部门推出更严格的指导方针并减少抗生素的使用。虽然这些措施有助于提高长期可持续性，但可能会限制某些药物类别的短期成长。

市场趋势

影响动物保健市场的一大趋势是先进疗法的兴起，包括基因疗法、单株抗体和细胞疗法。这些创新技术能够针对复杂的动物疾病进行标靶、个人化治疗，同时减少副作用。另一个值得关注的趋势是向永续兽医学的转变，製造商专注于环境友善配方，并减少驱虫产品对生态环境的影响。

依细分市场分析

按产品类型划分，驱虫药占据市场主导地位，由于家畜和伴侣动物寄生虫感染的普遍存在，驱虫药占据了最大的市场份额。抗发炎药物维持了第二大市场份额，这主要得益于宠物骨关节炎和术后疼痛管理需求的成长。抗感染药物持续发挥重要作用，尤其是在畜牧疾病管理方面。

按动物类型划分，伴侣动物市场占据主导地位，这得益于宠物主人数量的增长、医疗保健支出的增加以及预防医学意识的提高。畜牧业也维持了强劲的市场份额，这主要归功于全球对肉类、乳製品和水产养殖产品需求的成长。

按给药途径划分，口服兽药因其给药方便且宠物主人依从性高而占据了大部分市场份额。同时，因其起效迅速而备受青睐的注射剂型需求也在不断增长，而外用和气雾剂型则继续保持着一定的应用前景。

按分销管道划分，兽医诊所占据了最大的市场份额，这得益于其先进的治疗设施和专业兽医的聚集。诊所和药局持续扩大常规兽药的供应范围。

区域展望

北美将在2025年以38.57%的市场份额引领兽药市场，这得益于其较高的宠物拥有率、先进的兽医基础设施以及积极的研发活动。欧洲市场持续稳定成长，这主要得益于宠物拥有量的增加以及监管机构对合理用药的重视。亚太地区正崛起为高成长地区，这得益于畜牧业的扩张、可支配收入的提高以及政府支持的动物健康计画。拉丁美洲以及中东和非洲地区由于畜牧业的扩张和对动物性蛋白质需求的增加，呈现温和成长态势。

关键成长因素包括人们对动物保健意识的提高、政府主导的疾病控制措施以及伴侣动物日益人性化，这些因素推动了对先进、高品质治疗的需求。然而，抗菌素抗药性和非法兽药的流通等挑战正在推动更严格的监管和更合理的用药。从区域来看，北美保持领先地位，而亚太地区则凭藉畜牧业生产的扩张和收入的成长，成为高成长市场。总体而言，全球动物保健市场预计将保持韧性，以创新为驱动，对动物健康和公共卫生都至关重要，这与本报告涵盖的年份（2025年、2026年和2034年）密切相关。

目录

第一章：引言

第二章：执行摘要

第三章：市场动态

  • 市场驱动因素
  • 市场限制因素
  • 市场机遇
  • 市场趋势

第四章：关键考虑因素

  • 动物疾病概览：依主要国家及地区划分（2026年）
  • 在开发产品分析
  • 监管状况：按主要国家和地区划分（2026 年）
  • 价格分析
  • 宠物拥有量统计资料：按主要国家和地区划分（2026 年）
  • 新疗法与在研疗法概述
  • 各种动物疾病治疗方案概述
  • 主要公司新产品发布
  • 主要趋势：併购、联盟等
  • 新冠疫情对全球动物保健市场的影响

第五章：全球动物保健市场分析、洞察与预测（2021-2034 年）

  • 市场分析、洞察与预测：依产品分类
    • 抗感染药
    • 抗发炎药
    • 驱虫药
    • 其他
  • 市场分析、洞察与预测：依动物种类分类类型
    • 伴侣动物
      • 猫
      • 狗
      • 鸟类
      • 其他
    • 牲畜
      • 家禽
      • 猪
      • 牛
      • 其他
  • 市场分析、洞察与预测：依给药途径
    • 口服
    • 注射
    • 外用
    • 气雾剂
  • 市场分析、洞察与预测：依销售管道
    • 兽医院
    • 兽医诊所
    • 药局和药局
    • 其他
  • 市场分析、洞察与预测：按地区
    • 北部美洲
    • 欧洲
    • 亚太地区
    • 拉丁美洲
    • 中东和非洲

第六章 北美动物保健市场分析：洞察与预测（2021-2034）

  • 依国家划分
    • 美国
    • 加拿大

第七章 欧洲动物保健市场分析：洞察与预测（2021-2034）

  • 依国家划分
    • 德国
    • 英国
    • 法国
    • 义大利
    • 西班牙
    • 斯堪的纳维亚半岛
    • 欧洲其他地区

第八章 亚太地区动物保健市场分析：洞察与预测（2021-2034）

  • 依国家划分
    • 中国
    • 日本
    • 印度
    • 澳大利亚
    • 东南亚
    • 亚太其他地区

第九章：拉丁美洲动物保健市场分析：洞察与预测（2021-2034）

  • 依国家划分
    • 巴西
    • 墨西哥
    • 其他拉丁美洲国家

第十章：中东与非洲动物保健市场分析：洞察与预测（2021-2034）

  • 依国家划分
    • 海湾合作委员会
    • 南非
    • 中东其他地区非洲

第十一章 竞争分析

  • 世界市场占有率分析(2026年)
  • 企业简介
    • Zoetis Services LLC
    • Merck &Co., Inc.
    • Elanco Animal Health Incorporated
    • Boehringer Ingelheim International GmbH.
    • Ceva
    • Vetoquinol
    • Dechra Pharmaceuticals Limited
    • Virbac Corporation
Product Code: FBI100171

Growth Factors of veterinary drugs Market

The global veterinary drugs market plays a vital role in safeguarding animal health, ensuring food security, and controlling zoonotic disease transmission. According to the report timeline, the global veterinary drugs market size was valued at USD 30.54 billion in 2025. Supported by rising animal disease prevalence, expanding pet ownership, and growing demand for animal-derived protein, the market is projected to grow to USD 32.20 billion in 2026. Over the long-term forecast period, the market is expected to reach USD 53.05 billion by 2034, reflecting steady and sustained growth across both companion and livestock animal segments.

Veterinary drugs are used to prevent, diagnose, mitigate, and treat diseases in animals while supporting optimal physiological functions. These drugs include anti-infectives, parasiticides, anti-inflammatory agents, and other therapeutic categories that address widespread animal health issues such as bovine respiratory disease, foot-and-mouth disease, avian influenza, mastitis, parasitic infestations, and dermatological disorders. The rising frequency of zoonotic and infectious diseases globally continues to reinforce the importance of effective veterinary therapeutics.

Market Dynamics

A major driver of the veterinary drugs market is the rising prevalence of veterinary diseases across livestock and companion animals. Increased disease incidence has led to higher demand for preventive and therapeutic treatments, especially in regions with large livestock populations and dense animal farming practices. Governments and animal health organizations are actively supporting vaccination programs, disease surveillance, and awareness initiatives, further boosting drug adoption.

Another significant growth driver is the increase in pet ownership and humanization of companion animals. Pet owners increasingly view animals as family members and are willing to invest in advanced veterinary care, routine medications, and preventive treatments. This trend has expanded demand for premium veterinary drugs, including biologics, monoclonal antibodies, and pain management therapies.

However, the market faces restraints due to the presence of illegal and counterfeit veterinary medicines. Unauthorized products pose risks to animal health, food safety, and public health by contributing to antimicrobial resistance and undermining trust in regulated pharmaceuticals. Regulatory bodies continue to intensify enforcement efforts to curb illegal drug circulation.

Market Opportunities and Challenges

The growing global pet population and rising disposable income present strong opportunities for veterinary drug manufacturers. Increased spending on routine veterinary care, vaccinations, and chronic disease management is creating demand for innovative and specialized drugs. Expansion of veterinary services in emerging economies further supports market potential.

Conversely, the market faces challenges related to antimicrobial resistance (AMR). Overuse and misuse of antibiotics in animals have accelerated resistance development, prompting stricter regulatory guidelines and reduced antibiotic usage. While these measures improve long-term sustainability, they may limit short-term growth for certain drug classes.

Market Trends

A prominent trend shaping the veterinary drugs market is the emergence of advanced therapies, including gene therapy, monoclonal antibodies, and cell-based treatments. These innovations enable targeted and personalized treatment for complex animal diseases while reducing adverse effects. Another notable trend is the shift toward sustainable veterinary practices, with manufacturers focusing on environmentally friendly formulations and reduced ecological impact of parasiticides.

Segmentation Insights

By product type, parasiticides dominated the market, accounting for the largest share due to widespread parasite infestations in livestock and companion animals. Anti-inflammatory drugs held the second-largest share, driven by rising osteoarthritis and post-surgical pain management needs in pets. Anti-infectives continue to play a critical role, particularly in livestock disease control.

By animal type, the companion animal segment dominated the market, supported by increasing pet ownership, higher healthcare spending, and growing awareness of preventive care. The livestock segment also maintained a strong share due to rising global demand for meat, dairy, and aquaculture products.

By route of administration, oral veterinary drugs held the dominant market share, attributed to ease of administration and high owner compliance. Parenteral formulations are gaining traction for their rapid efficacy, while topical and aerosol routes maintain niche usage.

By distribution channel, veterinary hospitals held the largest share, driven by availability of advanced treatment facilities and specialized veterinary professionals. Clinics and pharmacies continue to expand access to routine veterinary medicines.

Regional Outlook

North America dominated the veterinary drugs market with a 38.57% share in 2025, supported by high pet ownership rates, advanced veterinary infrastructure, and strong R&D activity. Europe follows with steady growth driven by rising pet adoption and regulatory emphasis on responsible drug use. Asia Pacific is emerging as a high-growth region due to expanding livestock farming, increasing disposable income, and government-supported animal health programs. Latin America and the Middle East & Africa are witnessing moderate growth, supported by livestock production expansion and rising demand for animal protein.

Competitive Landscape

The veterinary drugs market is moderately consolidated, with key players such as Zoetis Services LLC, Elanco Animal Health Incorporated, Merck Animal Health, Boehringer Ingelheim International GmbH, and Virbac focusing on R&D investment, product innovation, and strategic acquisitions to strengthen their market positions.

Strictly aligned with the report years 2025, 2026, and 2034, the global veterinary drugs market demonstrates stable growth momentum, supported by rising animal health awareness, expanding companion animal care, and continuous advancements in veterinary therapeutics.

Conclusion

The global veterinary drugs market is on a stable growth trajectory, underpinned by rising animal disease prevalence, expanding pet ownership, and increasing demand for safe and high-quality animal protein. Valued at USD 30.54 billion in 2025, the market's growth to USD 32.20 billion in 2026 reflects steady adoption of preventive and therapeutic solutions across companion and livestock animals. The long-term outlook, reaching USD 53.05 billion by 2034, highlights the sustained importance of veterinary pharmaceuticals in animal health management and food security.

Key growth drivers include heightened awareness of animal healthcare, government-backed disease control initiatives, and the growing humanization of companion animals, which is driving demand for advanced and premium therapies. At the same time, challenges such as antimicrobial resistance and the circulation of illegal veterinary medicines are prompting stricter regulations and more responsible drug usage. Regionally, North America maintains leadership, while Asia Pacific is emerging as a high-growth market supported by livestock expansion and rising incomes. Overall, strictly aligned with the report years 2025, 2026, and 2034, the veterinary drugs market is expected to remain resilient, innovation-driven, and critical to both animal and public health worldwide.

Segmentation By Product

  • Anti-infectives
  • Anti-Inflammatory
  • Parasiticides
  • Others

By Animal Type

  • Companion
    • Feline
    • Canine
    • Avian
    • Others
  • Livestock
    • Poultry
    • Porcine
    • Bovine
    • Others

By Route of Administration

  • Oral
  • Parenteral
  • Topical
  • Aerosol

By Distribution Channel

  • Veterinary Hospitals
  • Veterinary Clinics
  • Pharmacies & Drug Stores
  • Others

By Region

  • North America (By Product, Animal, Route of Administration, Distribution Channel, Country/Sub-Region)
    • U.S.
    • Canada
  • Europe (By Product, Animal, Route of Administration, Distribution Channel, Country/Sub-Region)
    • U.K.
    • Germany
    • France
    • Italy
    • Spain
    • Scandinavia
    • Rest of Europe
  • Asia Pacific (By Product, Animal, Route of Administration, Distribution Channel, Country/Sub-Region)
    • Japan
    • China
    • India
    • Australia
    • Southeast Asia
    • Rest of Asia Pacific
  • Latin America (By Product, Animal, Route of Administration, Distribution Channel, Country/Sub-Region)
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East & Africa (By Product, Animal, Route of Administration, Distribution Channel, Country/Sub-Region)
    • GCC
    • South Africa
    • Rest of the Middle East & Africa

Table of Content

1. Introduction

  • 1.1. Research Scope
  • 1.2. Market Segmentation
  • 1.3. Research Methodology
  • 1.4. Definitions and Assumptions

2. Executive Summary

3. Market Dynamics

  • 3.1. Market Drivers
  • 3.2. Market Restraints
  • 3.3. Market Opportunities
  • 3.4. Market Trends

4. Key Insights

  • 4.1. Overview of Animal Diseases by Key Countries, By Key Countries/ Region, 2026
  • 4.2. Pipeline Analysis
  • 4.3. Regulatory Scenario By Key Countries/ Region, 2026
  • 4.4. Pricing Analysis
  • 4.5. Pet Ownership Statistics, By Key Countries/ Region, 2026
  • 4.6. Snapshot on the Novel & Upcoming Therapies
  • 4.7. Overview of Treatment Plans for Different Animal Diseases
  • 4.8. New Product Launches, By Key Players
  • 4.9. Key Industry Developments (Mergers, Acquisitions, Partnerships, etc.)
  • 4.10. Impact of COVID-19 on the Global Veterinary Drugs Market

5. Global Veterinary Drugs Market Analysis, Insights and Forecast, 2021-2034

  • 5.1. Market Analysis, Insights and Forecast - By Product
    • 5.1.1. Anti-infectives
    • 5.1.2. Anti-inflammatory
    • 5.1.3. Parasiticides
    • 5.1.4. Others
  • 5.2. Market Analysis, Insights and Forecast - By Animal Type
    • 5.2.1. Companion
      • 5.2.1.1. Feline
      • 5.2.1.2. Canine
      • 5.2.1.3. Avian
      • 5.2.1.4. Others
    • 5.2.2. Livestock
      • 5.2.2.1. Poultry
      • 5.2.2.2. Porcine
      • 5.2.2.3. Bovine
      • 5.2.2.4. Others
  • 5.3. Market Analysis, Insights and Forecast - By Route of Administration
    • 5.3.1. Oral
    • 5.3.2. Parenteral
    • 5.3.3. Topical
    • 5.3.4. Aerosol
  • 5.4. Market Analysis, Insights and Forecast - By Distribution Channel
    • 5.4.1. Veterinary Hospitals
    • 5.4.2. Veterinary Clinics
    • 5.4.3. Pharmacies & Drug Stores
    • 5.4.4. Others
  • 5.5. Market Analysis, Insights and Forecast - Region
    • 5.5.1. North America
    • 5.5.2. Europe
    • 5.5.3. Asia Pacific
    • 5.5.4. Latin America
    • 5.5.5. Middle East & Africa

6. North America Veterinary Drugs Market Analysis, Insights and Forecast, 2021-2034

  • 6.1. Market Analysis, Insights and Forecast - By Product
    • 6.1.1. Anti-infectives
    • 6.1.2. Anti-inflammatory
    • 6.1.3. Parasiticides
    • 6.1.4. Others
  • 6.2. Market Analysis, Insights and Forecast - By Animal Type
    • 6.2.1. Companion
      • 6.2.1.1. Feline
      • 6.2.1.2. Canine
      • 6.2.1.3. Avian
      • 6.2.1.4. Others
    • 6.2.2. Livestock
      • 6.2.2.1. Poultry
      • 6.2.2.2. Porcine
      • 6.2.2.3. Bovine
      • 6.2.2.4. Others
  • 6.3. Market Analysis, Insights and Forecast - By Route of Administration
    • 6.3.1. Oral
    • 6.3.2. Parenteral
    • 6.3.3. Topical
    • 6.3.4. Aerosol
  • 6.4. Market Analysis, Insights and Forecast - By Distribution Channel
    • 6.4.1. Veterinary Hospitals
    • 6.4.2. Veterinary Clinics
    • 6.4.3. Pharmacies & Drug Stores
    • 6.4.4. Others
  • 6.5. Market Analysis, Insights and Forecast - By Country
    • 6.5.1. U.S.
    • 6.5.2. Canada

7. Europe Veterinary Drugs Market Analysis, Insights and Forecast, 2021-2034

  • 7.1. Market Analysis, Insights and Forecast - By Product
    • 7.1.1. Anti-infectives
    • 7.1.2. Anti-inflammatory
    • 7.1.3. Parasiticides
    • 7.1.4. Others
  • 7.2. Market Analysis, Insights and Forecast - By Animal Type
    • 7.2.1. Companion
      • 7.2.1.1. Feline
      • 7.2.1.2. Canine
      • 7.2.1.3. Avian
      • 7.2.1.4. Others
    • 7.2.2. Livestock
      • 7.2.2.1. Poultry
      • 7.2.2.2. Porcine
      • 7.2.2.3. Bovine
      • 7.2.2.4. Others
  • 7.3. Market Analysis, Insights and Forecast - By Route of Administration
    • 7.3.1. Oral
    • 7.3.2. Parenteral
    • 7.3.3. Topical
    • 7.3.4. Aerosol
  • 7.4. Market Analysis, Insights and Forecast - By Distribution Channel
    • 7.4.1. Veterinary Hospitals
    • 7.4.2. Veterinary Clinics
    • 7.4.3. Pharmacies & Drug Stores
    • 7.4.4. Others
  • 7.5. Market Analysis, Insights and Forecast - By Country/ Sub-Region
    • 7.5.1. Germany
    • 7.5.2. U.K.
    • 7.5.3. France
    • 7.5.4. Italy
    • 7.5.5. Spain
    • 7.5.6. Scandinavia
    • 7.5.7. Rest of Europe

8. Asia Pacific Veterinary Drugs Market Analysis, Insights and Forecast, 2021-2034

  • 8.1. Market Analysis, Insights and Forecast - By Product
    • 8.1.1. Anti-infectives
    • 8.1.2. Anti-inflammatory
    • 8.1.3. Parasiticides
    • 8.1.4. Others
  • 8.2. Market Analysis, Insights and Forecast - By Animal Type
    • 8.2.1. Companion
      • 8.2.1.1. Feline
      • 8.2.1.2. Canine
      • 8.2.1.3. Avian
      • 8.2.1.4. Others
    • 8.2.2. Livestock
      • 8.2.2.1. Poultry
      • 8.2.2.2. Porcine
      • 8.2.2.3. Bovine
      • 8.2.2.4. Others
  • 8.3. Market Analysis, Insights and Forecast - By Route of Administration
    • 8.3.1. Oral
    • 8.3.2. Parenteral
    • 8.3.3. Topical
    • 8.3.4. Aerosol
  • 8.4. Market Analysis, Insights and Forecast - By Distribution Channel
    • 8.4.1. Veterinary Hospitals
    • 8.4.2. Veterinary Clinics
    • 8.4.3. Pharmacies & Drug Stores
    • 8.4.4. Others
  • 8.5. Market Analysis, Insights and Forecast - By Country/ Sub-Region
    • 8.5.1. China
    • 8.5.2. Japan
    • 8.5.3. India
    • 8.5.4. Australia
    • 8.5.5. Southeast Asia
    • 8.5.6. Rest of Asia Pacific

9. Latin America Veterinary Drugs Market Analysis, Insights and Forecast, 2021-2034

  • 9.1. Market Analysis, Insights and Forecast - By Product
    • 9.1.1. Anti-infectives
    • 9.1.2. Anti-inflammatory
    • 9.1.3. Parasiticides
    • 9.1.4. Others
  • 9.2. Market Analysis, Insights and Forecast - By Animal Type
    • 9.2.1. Companion
      • 9.2.1.1. Feline
      • 9.2.1.2. Canine
      • 9.2.1.3. Avian
      • 9.2.1.4. Others
    • 9.2.2. Livestock
      • 9.2.2.1. Poultry
      • 9.2.2.2. Porcine
      • 9.2.2.3. Bovine
      • 9.2.2.4. Others
  • 9.3. Market Analysis, Insights and Forecast - By Route of Administration
    • 9.3.1. Oral
    • 9.3.2. Parenteral
    • 9.3.3. Topical
    • 9.3.4. Aerosol
  • 9.4. Market Analysis, Insights and Forecast - By Distribution Channel
    • 9.4.1. Veterinary Hospitals
    • 9.4.2. Veterinary Clinics
    • 9.4.3. Pharmacies & Drug Stores
    • 9.4.4. Others
  • 9.5. Market Analysis, Insights and Forecast - By Country/ Sub-Region
    • 9.5.1. Brazil
    • 9.5.2. Mexico
    • 9.5.3. Rest of Latin America

10. Middle East & Africa Veterinary Drugs Market Analysis, Insights and Forecast, 2021-2034

  • 10.1. Market Analysis, Insights and Forecast - By Product
    • 10.1.1. Anti-infectives
    • 10.1.2. Anti-inflammatory
    • 10.1.3. Parasiticides
    • 10.1.4. Others
  • 10.2. Market Analysis, Insights and Forecast - By Animal Type
    • 10.2.1. Companion
      • 10.2.1.1. Feline
      • 10.2.1.2. Canine
      • 10.2.1.3. Avian
      • 10.2.1.4. Others
    • 10.2.2. Livestock
      • 10.2.2.1. Poultry
      • 10.2.2.2. Porcine
      • 10.2.2.3. Bovine
      • 10.2.2.4. Others
  • 10.3. Market Analysis, Insights and Forecast - By Route of Administration
    • 10.3.1. Oral
    • 10.3.2. Parenteral
    • 10.3.3. Topical
    • 10.3.4. Aerosol
  • 10.4. Market Analysis, Insights and Forecast - By Distribution Channel
    • 10.4.1. Veterinary Hospitals
    • 10.4.2. Veterinary Clinics
    • 10.4.3. Pharmacies & Drug Stores
    • 10.4.4. Others
  • 10.5. Market Analysis, Insights and Forecast - By Country/ Sub-Region
    • 10.5.1. GCC
    • 10.5.2. South Africa
    • 10.5.3. Rest of Middle East & Africa

11. Competitive Analysis

  • 11.1. Global Market Share Analysis (2026)
  • 11.2. Company Profiles
    • 11.2.1. Zoetis Services LLC
      • 11.2.1.1. Overview
      • 11.2.1.2. Products
      • 11.2.1.3. SWOT Analysis
      • 11.2.1.4. Recent Developments
      • 11.2.1.5. Strategies
      • 11.2.1.6. Financials (Based on Availability)
    • 11.2.2. Merck & Co., Inc.
      • 11.2.2.1. Overview
      • 11.2.2.2. Products
      • 11.2.2.3. SWOT Analysis
      • 11.2.2.4. Recent Developments
      • 11.2.2.5. Strategies
      • 11.2.2.6. Financials (Based on Availability)
    • 11.2.3. Elanco Animal Health Incorporated
      • 11.2.3.1. Overview
      • 11.2.3.2. Products
      • 11.2.3.3. SWOT Analysis
      • 11.2.3.4. Recent Developments
      • 11.2.3.5. Strategies
      • 11.2.3.6. Financials (Based on Availability)
    • 11.2.4. Boehringer Ingelheim International GmbH.
      • 11.2.4.1. Overview
      • 11.2.4.2. Products
      • 11.2.4.3. SWOT Analysis
      • 11.2.4.4. Recent Developments
      • 11.2.4.5. Strategies
      • 11.2.4.6. Financials (Based on Availability)
    • 11.2.5. Ceva
      • 11.2.5.1. Overview
      • 11.2.5.2. Products
      • 11.2.5.3. SWOT Analysis
      • 11.2.5.4. Recent Developments
      • 11.2.5.5. Strategies
      • 11.2.5.6. Financials (Based on Availability)
    • 11.2.6. Vetoquinol
      • 11.2.6.1. Overview
      • 11.2.6.2. Products
      • 11.2.6.3. SWOT Analysis
      • 11.2.6.4. Recent Developments
      • 11.2.6.5. Strategies
      • 11.2.6.6. Financials (Based on Availability)
    • 11.2.7. Dechra Pharmaceuticals Limited
      • 11.2.7.1. Overview
      • 11.2.7.2. Products
      • 11.2.7.3. SWOT Analysis
      • 11.2.7.4. Recent Developments
      • 11.2.7.5. Strategies
      • 11.2.7.6. Financials (Based on Availability)
    • 11.2.8. Virbac Corporation
      • 11.2.8.1. Overview
      • 11.2.8.2. Products
      • 11.2.8.3. SWOT Analysis
      • 11.2.8.4. Recent Developments
      • 11.2.8.5. Strategies
      • 11.2.8.6. Financials (Based on Availability)

List of Tables

  • Table 1: Global Veterinary Drug Market Revenue (USD billion) Forecast, by Product, 2019-2032
  • Table 2: Global Veterinary Drug Market Revenue (USD billion) Forecast, by Animal Type, 2019-2032
  • Table 3: Global Veterinary Drug Market Revenue (USD billion) Forecast, by Companion, 2019-2032
  • Table 4: Global Veterinary Drug Market Revenue (USD billion) Forecast, by Livestock, 2019-2032
  • Table 5: Global Veterinary Drug Market Revenue (USD billion) Forecast, by Route of Administration 2019-2032
  • Table 6: Global Veterinary Drug Market Revenue (USD billion) Forecast, by Distribution Channel 2019-2032
  • Table 7: Global Veterinary Drug Market Revenue (USD billion) Forecast, by Region, 2021-2034
  • Table 8: North America Veterinary Drug Market Revenue (USD billion) Forecast, by Product, 2019-2032
  • Table 9: North America Veterinary Drug Market Revenue (USD billion) Forecast, by Animal Type, 2019-2032
  • Table 10: North America Veterinary Drug Market Revenue (USD billion) Forecast, by Companion, 2019-2032
  • Table 11: North America Veterinary Drug Market Revenue (USD billion) Forecast, by Livestock, 2019-2032
  • Table 12: North America Veterinary Drug Market Revenue (USD billion) Forecast, by Route of Administration 2019-2032
  • Table 13: North America Veterinary Drug Market Revenue (USD billion) Forecast, by Distribution Channel 2019-2032
  • Table 14: North America Veterinary Drug Market Revenue (USD billion) Forecast, By Country, 2021-2034
  • Table 15: Europe Veterinary Drug Market Revenue (USD billion) Forecast, by Product, 2019-2032
  • Table 16: Europe Veterinary Drug Market Revenue (USD billion) Forecast, by Animal Type, 2019-2032
  • Table 17: Europe Veterinary Drug Market Revenue (USD billion) Forecast, by Companion, 2019-2032
  • Table 18: Europe Veterinary Drug Market Revenue (USD billion) Forecast, by Livestock, 2019-2032
  • Table 19: Europe Veterinary Drug Market Revenue (USD billion) Forecast, by Route of Administration 2019-2032
  • Table 20: Europe Veterinary Drug Market Revenue (USD billion) Forecast, by Distribution Channel 2019-2032
  • Table 21: Europe Veterinary Drug Market Revenue (USD billion) Forecast, By Country/ Sub-Region, 2021-2034
  • Table 22: Asia Pacific Veterinary Drug Market Revenue (USD billion) Forecast, by Product, 2019-2032
  • Table 23: Asia Pacific Veterinary Drug Market Revenue (USD billion) Forecast, by Animal Type, 2019-2032
  • Table 24: Asia Pacific Veterinary Drug Market Revenue (USD billion) Forecast, by Companion, 2019-2032
  • Table 25: Asia Pacific Veterinary Drug Market Revenue (USD billion) Forecast, by Livestock, 2019-2032
  • Table 26: Asia Pacific Veterinary Drug Market Revenue (USD billion) Forecast, by Route of Administration 2019-2032
  • Table 27: Asia Pacific Veterinary Drug Market Revenue (USD billion) Forecast, by Distribution Channel 2019-2032
  • Table 28: Asia Pacific Veterinary Drug Market Revenue (USD billion) Forecast, By Country/ Sub-Region, 2021-2034
  • Table 29: Latin America Veterinary Drug Market Revenue (USD billion) Forecast, by Product, 2019-2032
  • Table 30: Latin America Veterinary Drug Market Revenue (USD billion) Forecast, by Animal Type, 2019-2032
  • Table 31: Latin America Veterinary Drug Market Revenue (USD billion) Forecast, by Companion, 2019-2032
  • Table 32: Latin America Veterinary Drug Market Revenue (USD billion) Forecast, by Livestock, 2019-2032
  • Table 33: Latin America Veterinary Drug Market Revenue (USD billion) Forecast, by Route of Administration 2019-2032
  • Table 34: Latin America Veterinary Drug Market Revenue (USD billion) Forecast, by Distribution Channel 2019-2032
  • Table 35: Latin America Veterinary Drug Market Revenue (USD billion) Forecast, By Country/ Sub-Region, 2021-2034
  • Table 36: Middle East & Africa Veterinary Drug Market Revenue (USD billion) Forecast, by Product, 2019-2032
  • Table 37: Middle East & Africa Veterinary Drug Market Revenue (USD billion) Forecast, by Animal Type, 2019-2032
  • Table 38: Middle East & Africa Veterinary Drug Market Revenue (USD billion) Forecast, by Companion, 2019-2032
  • Table 39: Middle East & Africa Veterinary Drug Market Revenue (USD billion) Forecast, by Livestock, 2019-2032
  • Table 40: Middle East & Africa Veterinary Drug Market Revenue (USD billion) Forecast, by Route of Administration 2019-2032
  • Table 41: Middle East & Africa Veterinary Drug Market Revenue (USD billion) Forecast, by Distribution Channel 2019-2032
  • Table 42: Middle East & Africa Veterinary Drug Market Revenue (USD billion) Forecast, By Country/ Sub-Region, 2021-2034

List of Figures

  • Figure 1: Global Veterinary Drug Market Revenue Breakdown (USD billion, %) by Region, 2026-2034
  • Figure 2: Global Veterinary Drug Market Value Share (%), by Product, 2026-2034
  • Figure 3: Global Veterinary Drug Market Value Share (%), by Animal Type, 2026-2034
  • Figure 4: Global Veterinary Drug Market Value Share (%), by Route of Administration, 2026-2034
  • Figure 5: Global Veterinary Drug Market Value Share (%), by Distribution Channel, 2026-2034
  • Figure 6: Global Veterinary Drug Market Value (USD billion), by Region, 2026-2034
  • Figure 7: North America Veterinary Drug Market Value (USD billion), by Product, 2026-2034
  • Figure 8: North America Veterinary Drug Market Value Share (%), by Product, 2026
  • Figure 9: North America Veterinary Drug Market Value (USD billion), by Animal Type, 2026-2034
  • Figure 10: North America Veterinary Drug Market Value Share (%), by Animal Type, 2026
  • Figure 11: North America Veterinary Drug Market Value (USD billion), by Route of Administration, 2026-2034
  • Figure 14: North America Veterinary Drug Market Value Share (%), by Route of Administration, 2026
  • Figure 13: North America Veterinary Drug Market Value (USD billion), by Distribution Channel, 2026-2034
  • Figure 14: North America Veterinary Drug Market Value Share (%), by Distribution Channel, 2026
  • Figure 15: North America Veterinary Drug Market Value (USD billion), By Country, 2026-2034
  • Figure 16: North America Veterinary Drug Market Value Share (%), By Country, 2026
  • Figure 17: Europe Veterinary Drug Market Value (USD billion), by Product, 2026-2034
  • Figure 18: Europe Veterinary Drug Market Value Share (%), by Product, 2026
  • Figure 19: Europe Veterinary Drug Market Value (USD billion), by Animal Type, 2026-2034
  • Figure 20: Europe Veterinary Drug Market Value Share (%), by Animal Type, 2026
  • Figure 21: Europe Veterinary Drug Market Value (USD billion), by Route of Administration, 2026-2034
  • Figure 22: Europe Veterinary Drug Market Value Share (%), by Route of Administration, 2026
  • Figure 23: Europe Veterinary Drug Market Value (USD billion), by Distribution Channel, 2026-2034
  • Figure 24: Europe Veterinary Drug Market Value Share (%), by Distribution Channel, 2026
  • Figure 25: Europe Veterinary Drug Market Value (USD billion), By Country/Sub-Region, 2026-2034
  • Figure 26: Europe Veterinary Drug Market Value Share (%), By Country/Sub-Region, 2026
  • Figure 27: Asia Pacific Veterinary Drug Market Value (USD billion), by Product, 2026-2034
  • Figure 28: Asia Pacific Veterinary Drug Market Value Share (%), by Product, 2026
  • Figure 29: Asia Pacific Veterinary Drug Market Value (USD billion), by Animal Type, 2026-2034
  • Figure 30: Asia Pacific Veterinary Drug Market Value Share (%), by Animal Type, 2026
  • Figure 31: Asia Pacific Veterinary Drug Market Value (USD billion), by Route of Administration, 2026-2034
  • Figure 32: Asia Pacific Veterinary Drug Market Value Share (%), by Route of Administration, 2026
  • Figure 33: Asia Pacific Veterinary Drug Market Value (USD billion), by Distribution Channel, 2026-2034
  • Figure 34: Asia Pacific Veterinary Drug Market Value Share (%), by Distribution Channel, 2026
  • Figure 35: Asia Pacific Veterinary Drug Market Value (USD billion), By Country/Sub-Region, 2026-2034
  • Figure 36: Asia Pacific Veterinary Drug Market Value Share (%), By Country/Sub-Region, 2026
  • Figure 37: Latin America Veterinary Drug Market Value (USD billion), by Product, 2026-2034
  • Figure 38: Latin America Veterinary Drug Market Value Share (%), by Product, 2026
  • Figure 39: Latin America Veterinary Drug Market Value (USD billion), by Animal Type, 2026-2034
  • Figure 40: Latin America Veterinary Drug Market Value Share (%), by Animal Type, 2026
  • Figure 41: Latin America Veterinary Drug Market Value (USD billion), by Route of Administration, 2026-2034
  • Figure 42: Latin America Veterinary Drug Market Value Share (%), by Route of Administration, 2026
  • Figure 43: Latin America Veterinary Drug Market Value (USD billion), by Distribution Channel, 2026-2034
  • Figure 44: Latin America Veterinary Drug Market Value Share (%), by Distribution Channel, 2026
  • Figure 45: Latin America Veterinary Drug Market Value (USD billion), By Country/Sub-Region, 2026-2034
  • Figure 46: Latin America Veterinary Drug Market Value Share (%), By Country/Sub-Region, 2026
  • Figure 47: Middle East & Africa Veterinary Drug Market Value (USD billion), by Product, 2026-2034
  • Figure 48: Middle East & Africa Veterinary Drug Market Value Share (%), by Product, 2026
  • Figure 49: Middle East & Africa Veterinary Drug Market Value (USD billion), by Animal Type, 2026-2034
  • Figure 50: Middle East & Africa Veterinary Drug Market Value Share (%), by Animal Type, 2026
  • Figure 51: Middle East & Africa Veterinary Drug Market Value (USD billion), by Route of Administration, 2026-2034
  • Figure 52: Middle East & Africa Veterinary Drug Market Value Share (%), by Route of Administration, 2026
  • Figure 53: Middle East & Africa Veterinary Drug Market Value (USD billion), by Distribution Channel, 2026-2034
  • Figure 54: Middle East & Africa Veterinary Drug Market Value Share (%), by Distribution Channel, 2026
  • Figure 55: Middle East & Africa Veterinary Drug Market Value (USD billion), By Country/Sub-Region, 2026-2034
  • Figure 56: Middle East & Africa Veterinary Drug Market Value Share (%), By Country/Sub-Region, 2026
  • Figure 57: Global Veterinary Drug Market Share (%), By Company, 2026